Luminescent silicon-based nanocarrier for drug delivery in colorectal cancer cells
Source abstract
Abstract
Nanocarriers sensitive to exogenous or endogenous stimuli emerged as an attractive alternative to target drug delivery, with inorganic silica mesoporous nanoparticles (MNs) playing a core role in the development of a new generation of non-toxic and tuneable nanocarriers. A sensitive nanovector (NANO1) comprising luminescent silicon quantum dots (SiQDs) and functionalized with MNs was synthesised and loaded with doxorubicin (DOX). NANO1 nanoparticles have a size of 74 ± 10 nm and DOX loading percentages of ca. 43%. As a control sample, a similar nanocarrier (NANO2), without SiQDs, was also synthesised and loaded with DOX. Release profile studies, in PBS, revealed the strong NANO1@DOX pH-dependant behaviour, with a pH 5.0 favouring the release of DOX to percentages of ca. 70%. Cytotoxicity assessments of both free and DOX-loaded nanocarriers were evaluated in human cell lines of colon, revealing both free drug and drug-loaded nanoparticles to be concentration-dependent.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Silicon Nanostructures and Photoluminescence · Advanced biosensing and bioanalysis techniques · Quantum Dots Synthesis And Properties
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (47)
Show source-provided references
1. Ferlay Js · 2012
2. Strategies for advancing cancer nanomedicine10.1038/nmat3792 ↗
3. The EPR effect for macromolecular drug delivery to solid tumors: improvement of tumor uptake, lowering of systemic toxicity, and distinct tumor imaging in vivo10.1016/j.addr.2012.10.002 ↗
4. The smart drug delivery system and its clinical potential10.7150/thno.14858 ↗
5. Preparation and identification of multifunctional mesoporous silica nanoparticles for in vitro and in vivo dual-mode imaging, theranostics, and targeted tracking10.1016/j.biomaterials.2014.12.034 ↗
6. Biodegradable hollow mesoporous silica nanoparticles for regulating tumor microenvironment and enhancing antitumor efficiency10.7150/thno.19987 ↗
7. Co-encapsulation of biodegradable nanoparticles with silicon quantum dots and quercetin for monitored delivery10.1002/adhm.201200178 ↗
8. Quantum dot bioconjugates for ultrasensitive nonisotopic detection10.1126/science.281.5385.2016 ↗
9. Biocompatible luminescent silicon quantum dots for imaging of cancer cells10.1021/nn700319z ↗
10. Aqueous synthesized near-infrared-emitting quantum dots for RGD-based in vivo active tumour targeting10.1088/0957-4484/24/13/135101 ↗
11. Biodegradable luminescent porous silicon nanoparticles for in vivo applications10.1038/nmat2398 ↗
12. Quantum confinement in Si nanocrystals10.1103/PhysRevB.47.1397 ↗
13. Quantum confinement in size-selected, surface-oxidized silicon nanocrystals10.1126/science.262.5137.1242 ↗
14. Colloidal silicon quantum dots: from preparation to the modification of self-assembled monolayers (SAMs) for bio-applications10.1039/C3CS60353A ↗
15. Large-scale aqueous synthesis of fluorescent and biocompatible silicon nanoparticles and their use as highly photostable biological probes10.1021/ja4026227 ↗
16. Facile, large-quantity synthesis of stable, tunable-color silicon nanoparticles and their application for long-term cellular imaging10.1021/acsnano.5b00683 ↗
17. Surface-modified silicon nanoparticles with ultrabright photoluminescence and single-exponential decay for nanoscale fluorescence lifetime imaging of temperature10.1021/ja407508v ↗
18. One-step synthesis of water-dispersible silicon nanoparticles and their use in fluorescence lifetime imaging of living cells10.1039/C4TB00366G ↗
19. One-step synthesis of water-dispersible and biocompatible silicon nanoparticles for selective heparin sensing and cell imaging10.1021/acs.analchem.6b02448 ↗
20. Stimuli-responsive nanocarriers for drug delivery10.1038/nmat3776 ↗
21. Toxicological evaluation of luminescent silica nanoparticles as new drug nanocarriers in different cancer cell lines10.3390/ma11081310 ↗
22. Anti-CEA loaded maghemite nanoparticles as a theragnostic device for colorectal cancer
23. Nanoparticles functionalized with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells10.1016/j.biomaterials.2009.10.036 ↗
24. CEA-targeted nanoparticles allow specific in vivo fluorescent imaging of colorectal cancer models10.2217/nnm.14.202 ↗
25. Conatumumab (AMG 655) coated nanoparticles for targeted pro-apoptotic drug delivery10.1016/j.biomaterials.2011.07.065 ↗
26. Enhanced antitumor activity of the photosensitizer meso-Tetra(N-methyl-4-pyridyl) porphine tetra tosylate through encapsulation in antibody-targeted chitosan/alginate nanoparticles10.1021/bm301858a ↗
27. Influence of size, surface, cell line, and kinetic properties on the specific binding of A33 antigen-targeted multilayered particles and capsules to colorectal cancer cells10.1021/nn700060m ↗
28. Gold hybrid nanoparticles for targeted phototherapy and cancer imaging10.1088/0957-4484/21/10/105105 ↗
29. Folic acid-conjugated chitosan nanoparticles enhanced protoporphyrin IX accumulation in colorectal cancer cells10.1021/bc9004798 ↗
30. Synthesis and characterization of folate conjugated chitosan and cellular uptake of its nanoparticles in HT-29 cells10.1016/j.carres.2011.01.027 ↗
31. Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer10.3109/1061186X.2011.632011 ↗
32. Intracellular CXCR4(+) cell targeting with T22-empowered protein-only nanoparticles
33. Design and development of ligand-appended polysaccharidic nanoparticles for the delivery of oxaliplatin in colorectal cancer10.1016/j.nano.2009.03.002 ↗
34. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells10.1016/j.pdpdt.2011.12.010 ↗
35. Targeted delivery of small interfering RNA using reconstituted high-density lipoprotein nanoparticles10.1593/neo.101372 ↗
36. Stan MS, Sima C, Dinischiotu A. Silicon quantum dots: from synthesis to bioapplications. Bioactivity of Engineered Nanoparticles2017. p. 339-359.10.1007/978-981-10-5864-6_13 ↗
37. Magnetic, fluorescent and hybrid nanoparticles: from synthesis to application in biosystems10.1016/j.msec.2019.110104 ↗
38. Fabrication of antibacterial monodispersed Ag–SiO2 core–shell nanoparticles with high concentration10.1016/j.matlet.2008.08.039 ↗
39. A mesoporous silica nanosphere-based carrier system with chemically removable CdS nanoparticle caps for stimuli-responsive controlled release of neurotransmitters and drug molecules10.1021/ja028650l ↗
40. Adsorption of gases in multimolecular layers10.1021/ja01269a023 ↗
41. Radiationless intermolecular energy transfer. III. Determination of phosphorescence efficiencies10.1063/1.1725672 ↗
42. Mesoporous silica nanoparticles with large pores for the encapsulation and release of proteins10.1021/acsami.6b11324 ↗
43. Chemical insight into the origin of red and blue photoluminescence arising from freestanding silicon nanocrystals10.1021/nn4000644 ↗
44. Size vs surface: tuning the photoluminescence of freestanding silicon nanocrystals across the visible spectrum via surface groups10.1021/nn504109a ↗
45. Adsorption of bovine serum albumin on superparamagnetic composite microspheres with a Fe3O4/SiO2 core and mesoporous SiO2 shell10.1039/C5RA21773C ↗
46. Sustainable synthesis of luminescent CdTe quantum dots coated with modified silica mesoporous nanoparticles: towards new protein scavengers and smart drug delivery carriers10.1016/j.dyepig.2018.09.047 ↗
47. Use of the viability reagent PrestoBlue in comparison with alamarBlue and MTT to assess the viability of human corneal epithelial cells10.1016/j.vascn.2014.11.003 ↗